Cargando…

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice

BACKGROUND: Treatment complexity rises in line with the number of drugs, single doses, and administration methods, thereby threatening patient adherence. Patients with multimorbidity often need flexible, individualised treatment regimens, but alterations during the course of treatment may further in...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Buedingen, Fiona, Hammer, Marc S., Meid, Andreas D., Müller, Walter E., Gerlach, Ferdinand M., Muth, Christiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064613/ https://www.ncbi.nlm.nih.gov/pubmed/30055583 http://dx.doi.org/10.1186/s12875-018-0825-3

Ejemplares similares

Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice
por: Müller, Beate S, et al.
Publicado: (2020)

Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE)
por: McCarthy, Caroline, et al.
Publicado: (2020)

Evidence-Based Decision Support for a Structured Care Program on Polypharmacy in Multimorbidity: A Guideline Upgrade Based on a Realist Synthesis
por: Dinh, Truc Sophia, et al.
Publicado: (2022)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model
por: Dinh, Truc Sophia, et al.
Publicado: (2023)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot
por: McCarthy, Caroline, et al.
Publicado: (2017)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Health-related preferences of older patients with multimorbidity: the protocol for an evidence map
por: González-González, Ana Isabel, et al.
Publicado: (2019)

Health-related preferences of older patients with multimorbidity: an evidence map
por: Gonzalez, Ana Isabel, et al.
Publicado: (2019)

Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study
por: Dinh, Truc Sophia, et al.
Publicado: (2022)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

‘Potentially inappropriate or specifically appropriate?’ Qualitative evaluation of general practitioners views on prescribing, polypharmacy and potentially inappropriate prescribing in older people
por: Clyne, Barbara, et al.
Publicado: (2016)

Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot)
por: Muth, Christiane, et al.
Publicado: (2016)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study
por: Jungo, Katharina Tabea, et al.
Publicado: (2022)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Variation of polypharmacy in older primary care attenders occurs at prescriber level
por: Ong, Su Miin, et al.
Publicado: (2018)

Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada
por: Maxwell, Colleen J., et al.
Publicado: (2021)

Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial
por: del Cura-González, Isabel, et al.
Publicado: (2022)

End-of-life care preferences of older patients with multimorbidity: protocol of a mixed-methods systematic review
por: Gonzalez-Gonzalez, Ana Isabel, et al.
Publicado: (2020)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

End-of-Life Care Preferences of Older Patients with Multimorbidity: A Mixed Methods Systematic Review
por: González-González, Ana I., et al.
Publicado: (2020)

Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
por: Guo, Xueyuan, et al.
Publicado: (2022)

Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
por: Laberge, Maude, et al.
Publicado: (2021)

Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017)

Prescribing patterns of polypharmacy in Korean pediatric patients
por: Jeon, Soo-Min, et al.
Publicado: (2019)

Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
por: Randles, Mary A., et al.
Publicado: (2022)

Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review
por: Turk, Amadea, et al.
Publicado: (2022)

Sex Differences in Potentially Inappropriate Prescribing Among Older Adults With Multimorbidity
por: Ukhanova, Maria, et al.
Publicado: (2021)

Comprehension of Prescriptions and Errors in Taking Prescribed Medicines by Veterans – Polypharmacy a Problem Underrated
por: Singhal, Anuj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rmloov8msvhusbu7a365cptugf